Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience.

Yanjuan LiJunru LiuBeihui HuangMeilan ChenJingli GuJuan Li

Published in: Annals of medicine (2023)

For patients with NDMM, 24-h continuous infusion of CTX plus G-CSF contributes to improved mobilization efficiency and equivalent toxicity as a stem cell mobilization regimen.

Keyphrases

newly diagnosed
stem cells
low dose
multiple myeloma
end stage renal disease
ejection fraction
high dose
prognostic factors
peripheral blood
escherichia coli
cerebrospinal fluid